@darbymoss | YES | 100¢ | +5 SP | AG1 next major corporate finance event by end of 2026: No qualifying corporate finance event | |
@frankieramos | YES | 53¢ | +8 SP | Will AG1 (Athletic Greens) launch a new product SKU by July 15, 2026? | |
@averydiaz | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: $4.0B – $4.5B | |
@darbymoss | YES | 100¢ | +5 SP | AG1 next major corporate finance event by end of 2026: IPO filing (S-1) | |
@alexingram | YES | 51¢ | +8 SP | Will Hims disclose >2M GLP-1 subscribers by July 31, 2026? | |
@darbymoss | YES | 100¢ | +6 SP | AG1 next major corporate finance event by end of 2026: Strategic acquisition (AG1 acquired) | |
@darbymoss | YES | 100¢ | +5 SP | AG1 next major corporate finance event by end of 2026: No qualifying corporate finance event | |
@violetalvarez | YES | 50¢ | +6 SP | Will AG1 (Athletic Greens) launch a new product SKU by July 15, 2026? | |
@laylalopez | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: $3.5B – $4.0B | |
@laylalopez | YES | 100¢ | +6 SP | Apple's biggest sleep feature launch in 2026: AirPods sleep tracking | |
@kairivera | YES | 47¢ | +8 SP | Will Hims disclose >2M GLP-1 subscribers by July 31, 2026? | |
@averykhan | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: $3.0B – $3.5B | |
@averydiaz | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: Under $3.0B | |
@averydiaz | YES | 43¢ | +8 SP | Will Function Health close a Series B by July 31, 2026? | |
@averydiaz | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: $3.5B – $4.0B | |
@quinngarza | YES | 47¢ | +40 SP | Will Oasis Health face a public pay-for-rating scandal by Dec 31, 2026? | |
@violetalvarez | YES | 61¢ | +6 SP | Will the FDA approve a generic semaglutide by July 31, 2026? | |
@laneshah | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: $3.5B – $4.0B | |
@morgancole | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: Under $3.0B | |
@reeseingram | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: $3.5B – $4.0B | |
@alexingram | YES | 100¢ | +5 SP | AG1 next major corporate finance event by end of 2026: Strategic acquisition (AG1 acquired) | |
@averykhan | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: $3.5B – $4.0B | |
@violetalvarez | YES | 100¢ | +5 SP | AG1 next major corporate finance event by end of 2026: IPO filing (S-1) | |
@charlotteortiz | YES | 100¢ | +6 SP | Apple's biggest sleep feature launch in 2026: AirPods sleep tracking | |
@ellachen | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: $3.0B – $3.5B | |
@daisykhan | YES | 100¢ | +5 SP | Apple's biggest sleep feature launch in 2026: AirPods sleep tracking | |
@averydiaz | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: $3.0B – $3.5B | |
@micahpowell | YES | 100¢ | +5 SP | AG1 next major corporate finance event by end of 2026: Strategic acquisition (AG1 acquired) | |
@laylalopez | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: $4.0B – $4.5B | |
@briarsantos | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: Under $3.0B | |
@campbellwalsh | YES | 55¢ | +8 SP | Will Ro (Roman Health) raise a new funding round by June 30, 2026? | |
@ellachen | YES | 46¢ | +8 SP | Will AG1 (Athletic Greens) launch a new product SKU by July 15, 2026? | |
@alexingram | YES | 100¢ | +5 SP | AG1 next major corporate finance event by end of 2026: Strategic acquisition (AG1 acquired) | |
@emersonhayes | YES | 100¢ | +5 SP | AG1 next major corporate finance event by end of 2026: Series D+ funding round | |
@sagehale | YES | 64¢ | +8 SP | Will the FDA approve a generic semaglutide by July 31, 2026? | |
@junejensen | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: $3.5B – $4.0B | |
@irisbrooks | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: Over $4.5B | |
@averykhan | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: $3.5B – $4.0B | |
@averykhan | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: $3.5B – $4.0B | |
@violetalvarez | YES | 100¢ | +5 SP | AG1 next major corporate finance event by end of 2026: Strategic acquisition (AG1 acquired) | |
@alexnash | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: $3.5B – $4.0B | |
@frankieramos | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: Over $4.5B | |
@haydeningram | YES | 100¢ | +5 SP | AG1 next major corporate finance event by end of 2026: Series D+ funding round | |
@averydiaz | YES | 100¢ | +5 SP | AG1 next major corporate finance event by end of 2026: No qualifying corporate finance event | |
@frankieramos | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: Over $4.5B | |
@charlotteortiz | YES | 51¢ | +8 SP | Will Ro (Roman Health) raise a new funding round by June 30, 2026? | |
@briarsantos | YES | 100¢ | +5 SP | AG1 next major corporate finance event by end of 2026: Strategic acquisition (AG1 acquired) | |
@laylalopez | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: $4.0B – $4.5B | |
@charlotteortiz | YES | 100¢ | +5 SP | Eli Lilly Q2 2026 Mounjaro revenue band: $3.5B – $4.0B | |
@alexingram | YES | 49¢ | +8 SP | Will AG1 (Athletic Greens) launch a new product SKU by July 15, 2026? | |